|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q64410110
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241120235928.0 |
|
008
|
|
|
241120nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q64410110
|
|
035
|
|
|
‡a
(OCoLC)Q64410110
|
|
100
|
0 |
|
‡a
Gertrud Mueller-Eckhardt
‡c
researcher
‡9
en
|
|
375
|
|
|
‡a
2
‡2
iso5218
|
|
400
|
0 |
|
‡a
Gertrud Mueller-Eckhardt
‡c
wetenschapper
‡9
nl
|
|
670
|
|
|
‡a
Author's 219 Zw(a) positive mothers of children with clinically suspected neonatal alloimmune thrombocytopenia
|
|
670
|
|
|
‡a
Author's 348 cases of suspected neonatal alloimmune thrombocytopenia
|
|
670
|
|
|
‡a
Author's A point mutation leads to an unpaired cysteine residue and a molecular weight polymorphism of a functional platelet beta 3 integrin subunit. The Sra alloantigen system of GPIIIa.
|
|
670
|
|
|
‡a
Author's Anti Ko(a) as a cause of neonatal alloimmune thrombocytopenia
|
|
670
|
|
|
‡a
Author's Clinical and serologic studies in 34 patients with post-transfusion purpura
|
|
670
|
|
|
‡a
Author's Detection of Platelet Autoantibodies by a Radioactive Anti-Immunoglobulin Test
|
|
670
|
|
|
‡a
Author's Detection of platelet-specific alloantigens in 400 unselected blood donors
|
|
670
|
|
|
‡a
Author's Diagnosis in patients with habitual abortion
|
|
670
|
|
|
‡a
Author's Die immunhämatologische Diagnostik neonataler Immunthrombozytopenien*
|
|
670
|
|
|
‡a
Author's Does platelet-associated IgE play a role in immunologically induced thrombocytopenias?
|
|
670
|
|
|
‡a
Author's Extensive HLA class II studies in 58 non-DRB1*15
|
|
670
|
|
|
‡a
Author's Extensive HLA class II studies in 58 non-DRB1*15 (DR2) narcoleptic patients with cataplexy
|
|
670
|
|
|
‡a
Author's Fc receptor-dependent platelet activation results independently of glycoprotein complex IIb/IIIa
|
|
670
|
|
|
‡a
Author's Heparin-associated thrombocytopenia: no association of immune response with HLA.
|
|
670
|
|
|
‡a
Author's HLA and narcolepsy in a German population
|
|
670
|
|
|
‡a
Author's HLA Antigens in Immunologic Thrombocytopenic Purpura (ITP)
|
|
670
|
|
|
‡a
Author's HLA antigens on platelet membranes. In vitro and in vivo studies
|
|
670
|
|
|
‡a
Author's HLA association of idiopathic Peyronie's disease: An indication of autoimmune phenomena in etiopathogenesis?
|
|
670
|
|
|
‡a
Author's HLA-DP antigens in patients with chronic autoimmune thrombocytopenia (AITP).
|
|
670
|
|
|
‡a
Author's HLA-DR in chronic idiopathic thrombocytopenic purpura (ITP).
|
|
670
|
|
|
‡a
Author's HLA phenotypes and multiple basal cell carcinomas
|
|
670
|
|
|
‡a
Author's Immune-haematological diagnosis of neonatal immunothrombocytopenia (author's transl)
|
|
670
|
|
|
‡a
Author's Immunization against a new, infrequent alloantigen (Iy) on the platelet glycoprotein Ib/IX as a cause of a serious case of neonatal alloimmune thrombocytopenia
|
|
670
|
|
|
‡a
Author's Immunogenicity of and immune response to the human platelet antigen Zwa is strongly associated with HLA-B8 and DR3.
|
|
670
|
|
|
‡a
Author's Immunotherapy with intravenous immunoglobulin for prevention of recurrent pregnancy loss: European experience
|
|
670
|
|
|
‡a
Author's Immunothrombocytopenia of the newborn caused by platelet-specific antibodies (anti-P1A1) (author's transl)
|
|
670
|
|
|
‡a
Author's Improved assay for detection of platelet-specific PlA1 antibodies in neonatal alloimmune thrombocytopenia
|
|
670
|
|
|
‡a
Author's Incidence and specificity of HLA-DP antibodies in pregnancy sera
|
|
670
|
|
|
‡a
Author's Influence of treatment with mouse immunoglobulin on the rate of viable neonates in the CBA/J x DBA/2 J model
|
|
670
|
|
|
‡a
Author's Intravenous immune globulin in recurrent abortion.
|
|
670
|
|
|
‡a
Author's Localization of the Br polymorphism on a 144 bp exon of the GPIa gene and its application in platelet DNA typing.
|
|
670
|
|
|
‡a
Author's Long-Term Support of a Patient with Aplastic Anemia by Platelets and Granulocytes from Donors of a HLA-A, B Identical Family
|
|
670
|
|
|
‡a
Author's Molecular biologic clarification of Br alloantigens in human platelets and its application in DNA typing
|
|
670
|
|
|
‡a
Author's Neonatal isoimmune thrombocytopenia by anti-GP IIb/IIIa
|
|
670
|
|
|
‡a
Author's Passive immunotherapy with polyvalent immunoglobulins in women with habitual abortions
|
|
670
|
|
|
‡a
Author's Platelet associated IgG, platelet survival, and platelet sequestration in thrombocytopenic states
|
|
670
|
|
|
‡a
Author's Platelet survival determined with 51Cr versus 111In
|
|
670
|
|
|
‡a
Author's Post-transfusion purpura: clinical and immunologic studies in 38 patients
|
|
670
|
|
|
‡a
Author's Posttransfusion purpura. A survey of 13 cases
|
|
670
|
|
|
‡a
Author's Prenatal management of fetuses with alloimmune thrombocytopenia
|
|
670
|
|
|
‡a
Author's Prevention of habitual abortion using intravenously administered polyvalent immunoglobulins
|
|
670
|
|
|
‡a
Author's Quantitation of HLA class II antigens on B-cell lines
|
|
670
|
|
|
‡a
Author's Reduced Immune Phagocytosis of Monocytes from Neonates Whose Mothers Produce HLA Antibodies
|
|
670
|
|
|
‡a
Author's Segregation of HLA genes in multicase narcolepsy families
|
|
670
|
|
|
‡a
Author's Sra, a private platelet antigen on glycoprotein IIIa associated with neonatal alloimmune thrombocytopenia.
|
|
670
|
|
|
‡a
Author's The Br(a)/Br(b) alloantigen system in thrombocytes
|
|
670
|
|
|
‡a
Author's The clinical significance of platelet-associated IgG: a study on 298 patients with various disorders.
|
|
670
|
|
|
‡a
Author's The value of platelet-associated IgG in predicting the efficacy of splenectomy in autoimmune thrombocytopenia.
|
|
919
|
|
|
‡a
clinicalsignificanceofplateletassociatediggastudyon298patientswithvariousdisorders
‡A
The clinical significance of platelet-associated IgG: a study on 298 patients with various disorders.
‡9
1
|
|
919
|
|
|
‡a
brabrballoantigensysteminthrombocytes
‡A
The Br(a)/Br(b) alloantigen system in thrombocytes
‡9
1
|
|
919
|
|
|
‡a
sraaprivateplateletantigenonglycoproteiniiiaassociatedwithneonatalalloimmunethrombocytopenia
‡A
Sra, a private platelet antigen on glycoprotein IIIa associated with neonatal alloimmune thrombocytopenia.
‡9
1
|
|
919
|
|
|
‡a
segregationofhlagenesinmulticasenarcolepsyfamilies
‡A
Segregation of HLA genes in multicase narcolepsy families
‡9
1
|
|
919
|
|
|
‡a
reducedimmunephagocytosisofmonocytesfromneonateswhosemothersproducehlaantibodies
‡A
Reduced Immune Phagocytosis of Monocytes from Neonates Whose Mothers Produce HLA Antibodies
‡9
1
|
|
919
|
|
|
‡a
quantitationofhlaclass2antigensonbcelllines
‡A
Quantitation of HLA class II antigens on B-cell lines
‡9
1
|
|
919
|
|
|
‡a
preventionofhabitualabortionusingintravenouslyadministeredpolyvalentimmunoglobulins
‡A
Prevention of habitual abortion using intravenously administered polyvalent immunoglobulins
‡9
1
|
|
919
|
|
|
‡a
prenatalmanagementoffetuseswithalloimmunethrombocytopenia
‡A
Prenatal management of fetuses with alloimmune thrombocytopenia
‡9
1
|
|
919
|
|
|
‡a
posttransfusionpurpuraasurveyof13cases
‡A
Posttransfusion purpura. A survey of 13 cases
‡9
1
|
|
919
|
|
|
‡a
posttransfusionpurpuraclinicalandimmunologicstudiesin38patients
‡A
Post-transfusion purpura: clinical and immunologic studies in 38 patients
‡9
1
|
|
919
|
|
|
‡a
plateletsurvivaldeterminedwith51crversus111in
‡A
Platelet survival determined with 51Cr versus 111In
‡9
1
|
|
919
|
|
|
‡a
plateletassociatediggplateletsurvivalandplateletsequestrationinthrombocytopenicstates
‡A
Platelet associated IgG, platelet survival, and platelet sequestration in thrombocytopenic states
‡9
1
|
|
919
|
|
|
‡a
passiveimmunotherapywithpolyvalentimmunoglobulinsinwomenwithhabitualabortions
‡A
Passive immunotherapy with polyvalent immunoglobulins in women with habitual abortions
‡9
1
|
|
919
|
|
|
‡a
neonatalisoimmunethrombocytopeniabyantigpiibiiia
‡A
Neonatal isoimmune thrombocytopenia by anti-GP IIb/IIIa
‡9
1
|
|
919
|
|
|
‡a
molecularbiologicclarificationofbralloantigensinhumanplateletsanditsapplicationindnatyping
‡A
Molecular biologic clarification of Br alloantigens in human platelets and its application in DNA typing
‡9
1
|
|
919
|
|
|
‡a
longtermsupportofapatientwithaplasticanemiabyplateletsandgranulocytesfromdonorsofahlaabidenticalfamily
‡A
Long-Term Support of a Patient with Aplastic Anemia by Platelets and Granulocytes from Donors of a HLA-A, B Identical Family
‡9
1
|
|
919
|
|
|
‡a
localizationofthebrpolymorphismona144bpexonofthegpiageneanditsapplicationinplateletdnatyping
‡A
Localization of the Br polymorphism on a 144 bp exon of the GPIa gene and its application in platelet DNA typing.
‡9
1
|
|
919
|
|
|
‡a
intravenousimmuneglobulininrecurrentabortion
‡A
Intravenous immune globulin in recurrent abortion.
‡9
1
|
|
919
|
|
|
‡a
influenceoftreatmentwithmouseimmunoglobulinontherateofviableneonatesinthecbaj10dba2jmodel
‡A
Influence of treatment with mouse immunoglobulin on the rate of viable neonates in the CBA/J x DBA/2 J model
‡9
1
|
|
919
|
|
|
‡a
incidenceandspecificityofhladpantibodiesinpregnancysera
‡A
Incidence and specificity of HLA-DP antibodies in pregnancy sera
‡9
1
|
|
919
|
|
|
‡a
improvedassayfordetectionofplateletspecificpla1antibodiesinneonatalalloimmunethrombocytopenia
‡A
Improved assay for detection of platelet-specific PlA1 antibodies in neonatal alloimmune thrombocytopenia
‡9
1
|
|
919
|
|
|
‡a
immunothrombocytopeniaofthenewborncausedbyplateletspecificantibodiesantip1a1authorstransl
‡A
Immunothrombocytopenia of the newborn caused by platelet-specific antibodies (anti-P1A1) (author's transl)
‡9
1
|
|
919
|
|
|
‡a
immunotherapywithintravenousimmunoglobulinforpreventionofrecurrentpregnancylosseuropeanexperience
‡A
Immunotherapy with intravenous immunoglobulin for prevention of recurrent pregnancy loss: European experience
‡9
1
|
|
919
|
|
|
‡a
immunogenicityofandimmuneresponsetothehumanplateletantigenzwaisstronglyassociatedwithhlab8anddr3
‡A
Immunogenicity of and immune response to the human platelet antigen Zwa is strongly associated with HLA-B8 and DR3.
‡9
1
|
|
919
|
|
|
‡a
immunizationagainstanewinfrequentalloantigeniyontheplateletglycoproteinib9asacauseofaseriouscaseofneonatalalloimmunethrombocytopenia
‡A
Immunization against a new, infrequent alloantigen (Iy) on the platelet glycoprotein Ib/IX as a cause of a serious case of neonatal alloimmune thrombocytopenia
‡9
1
|
|
919
|
|
|
‡a
immunehaematologicaldiagnosisofneonatalimmunothrombocytopeniaauthorstransl
‡A
Immune-haematological diagnosis of neonatal immunothrombocytopenia (author's transl)
‡9
1
|
|
919
|
|
|
‡a
hlaphenotypesandmultiplebasalcellcarcinomas
‡A
HLA phenotypes and multiple basal cell carcinomas
‡9
1
|
|
919
|
|
|
‡a
hladrinchronicidiopathicthrombocytopenicpurpuraitp
‡A
HLA-DR in chronic idiopathic thrombocytopenic purpura (ITP).
‡9
1
|
|
919
|
|
|
‡a
hladpantigensinpatientswithchronicautoimmunethrombocytopeniaaitp
‡A
HLA-DP antigens in patients with chronic autoimmune thrombocytopenia (AITP).
‡9
1
|
|
919
|
|
|
‡a
hlaassociationofidiopathicpeyroniesdiseaseanindicationofautoimmunephenomenainetiopathogenesis
‡A
HLA association of idiopathic Peyronie's disease: An indication of autoimmune phenomena in etiopathogenesis?
‡9
1
|
|
919
|
|
|
‡a
hlaantigensonplateletmembranesinvitroandinvivostudies
‡A
HLA antigens on platelet membranes. In vitro and in vivo studies
‡9
1
|
|
919
|
|
|
‡a
hlaantigensinimmunologicthrombocytopenicpurpuraitp
‡A
HLA Antigens in Immunologic Thrombocytopenic Purpura (ITP)
‡9
1
|
|
919
|
|
|
‡a
hlaandnarcolepsyinagermanpopulation
‡A
HLA and narcolepsy in a German population
‡9
1
|
|
919
|
|
|
‡a
heparinassociatedthrombocytopenianoassociationofimmuneresponsewithhla
‡A
Heparin-associated thrombocytopenia: no association of immune response with HLA.
‡9
1
|
|
919
|
|
|
‡a
fcreceptordependentplateletactivationresultsindependentlyofglycoproteincomplexiibiiia
‡A
Fc receptor-dependent platelet activation results independently of glycoprotein complex IIb/IIIa
‡9
1
|
|
919
|
|
|
‡a
extensivehlaclass2studiesin58nondrb115dr2narcolepticpatientswithcataplexy
‡A
Extensive HLA class II studies in 58 non-DRB1*15 (DR2) narcoleptic patients with cataplexy
‡9
1
|
|
919
|
|
|
‡a
extensivehlaclass2studiesin58nondrb115
‡A
Extensive HLA class II studies in 58 non-DRB1*15
‡9
1
|
|
919
|
|
|
‡a
doesplateletassociatedigeplayaroleinimmunologicallyinducedthrombocytopenias
‡A
Does platelet-associated IgE play a role in immunologically induced thrombocytopenias?
‡9
1
|
|
919
|
|
|
‡a
immunhamatologischediagnostikneonatalerimmunthrombozytopenien
‡A
Die immunhämatologische Diagnostik neonataler Immunthrombozytopenien*
‡9
1
|
|
919
|
|
|
‡a
diagnosisinpatientswithhabitualabortion
‡A
Diagnosis in patients with habitual abortion
‡9
1
|
|
919
|
|
|
‡a
detectionofplateletspecificalloantigensin400unselectedblooddonors
‡A
Detection of platelet-specific alloantigens in 400 unselected blood donors
‡9
1
|
|
919
|
|
|
‡a
detectionofplateletautoantibodiesbyaradioactiveantiimmunoglobulintest
‡A
Detection of Platelet Autoantibodies by a Radioactive Anti-Immunoglobulin Test
‡9
1
|
|
919
|
|
|
‡a
clinicalandserologicstudiesin34patientswithposttransfusionpurpura
‡A
Clinical and serologic studies in 34 patients with post-transfusion purpura
‡9
1
|
|
919
|
|
|
‡a
antikoaasacauseofneonatalalloimmunethrombocytopenia
‡A
Anti Ko(a) as a cause of neonatal alloimmune thrombocytopenia
‡9
1
|
|
919
|
|
|
‡a
pointmutationleadstoanunpairedcysteineresidueandamolecularweightpolymorphismofafunctionalplateletbeta3integrinsubunitthesraalloantigensystemofgpiiia
‡A
A point mutation leads to an unpaired cysteine residue and a molecular weight polymorphism of a functional platelet beta 3 integrin subunit. The Sra alloantigen system of GPIIIa.
‡9
1
|
|
919
|
|
|
‡a
348casesofsuspectedneonatalalloimmunethrombocytopenia
‡A
348 cases of suspected neonatal alloimmune thrombocytopenia
‡9
1
|
|
919
|
|
|
‡a
219zwapositivemothersofchildrenwithclinicallysuspectedneonatalalloimmunethrombocytopenia
‡A
219 Zw(a) positive mothers of children with clinically suspected neonatal alloimmune thrombocytopenia
‡9
1
|
|
919
|
|
|
‡a
valueofplateletassociatedigginpredictingtheefficacyofsplenectomyinautoimmunethrombocytopenia
‡A
The value of platelet-associated IgG in predicting the efficacy of splenectomy in autoimmune thrombocytopenia.
‡9
1
|
|
946
|
|
|
‡a
a
‡9
1
|
|
996
|
|
|
‡2
SUDOC|263804437
|
|
996
|
|
|
‡2
NTA|310790220
|
|
996
|
|
|
‡2
LC|n 89657617
|
|
996
|
|
|
‡2
DNB|116851872
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
